
Low recurrence rates for in situ and invasive melanomas using Mohs micrographic surgery with melanoma antigen recognized by T cells 1 (MART-1) immunostaining: Tissue processing methodology to optimize pathologic staging and margin assessment
Keywords: خال سرطانی یا ملانوما; immunostaining; melanoma; melanoma antigen recognized by T cells 1; Mohs micrographic surgery; recurrence; upstagingAJCC, American Joint Committee on Cancer; MART, melanoma antigen recognized by T cells; MMS, Mohs micrographic surgery; SLNB, sentinel lymp